Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 5;54(3):537-544.
doi: 10.55730/1300-0144.5820. eCollection 2024.

Total kidney volume in autosomal dominant polycystic kidney disease: intraobserver and interobserver agreement of two methods with MRI

Affiliations

Total kidney volume in autosomal dominant polycystic kidney disease: intraobserver and interobserver agreement of two methods with MRI

Elif Gündoğdu et al. Turk J Med Sci. .

Abstract

Background/aim: Total kidney volume (TKV) is a parameter used in both treatment decision and follow-up in autosomal dominant polycystic kidney disease (ADPKD) patients. The objective of this study was to evaluate intra- and interobserver agreement of the ellipsoid formula (EF) and manual boundary tracing method (MBTM) used in TKV measurement of ADPKD patients across different levels of experience radiologists. Additionally, the study aimed to evaluate the correlation between the EF and MBTM, which is considered the gold standard for TKV.

Materials and methods: A retrospective evaluation was conducted on magnetic resonance imaging (MRI) data from 55 ADPKD patients who underwent abdominal MRI between January 2017 and November 2021 to evaluate TKV. TKV measurements were performed by three independent observers (observer 1, an abdominal imaging radiologist with 5 years of experience; observer 2, a fourth-year radiology resident; observer 3, a second-year radiology resident).To assess intraobserver variability, all observers repeated the measurements at two-week intervals. The ICC was used to assess both intraobserver and interobserver variability. A comparison of the two methods was performed by linear regression for all three observers.

Results: The ICC (95% CI) indicated excellent agreement between the observers for both methods (among all observers, p < 0.001). Furthermore, excellent intraobserver agreement was found between all observer measurements either EF or MBTM based on ICC (95% CI) (p < 0.001). The results of the linear regression analysis demonstrated high correlations between the two methods in all three observers (r = 0.992, p < 0.001 for the first observer; r = 0.975, p < 0.001 for the second observer; r = 0.989, p < 0.001 for the third observer).

Conclusion: Both the EF and MBTM methods used for the measurement of TKV provided excellent intra- and interobserver reproducibility. The EF is as accurate and precise as the MBTM. It may therefore be preferred in radiology departments with heavy workload, as it is a reliable method for rapid and easy assessment, independent of experience.

Keywords: Autosomal dominant polycystic kidney disease; ellipsoid formula; magnetic resonance imaging; manual boundary tracing method; total kidney volume.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
MBTM for TKV of ADPKD: kidney boundaries manually drawn on axial plane T2-weighted MRI.
Figure 2
Figure 2
EF for TKV of ADPKD: The width from the axial plane image at maximum transversal diameter, and depth from the same image perpendicular to the width measurement.
Figure 3
Figure 3
Linear regression analysis of measurement methods for all three observers A) first observer, B) second observer, and C) third observer.

References

    1. Grantham JJ, Geiser JL, Evan AP. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney International. 1987;31(5):1145–1152. doi: 10.1038/ki.1987.121. - DOI - PubMed
    1. Chebib FT, Torres VE. Autosomal dominant polycystic kidney disease: core curriculum 2016. American Journal of Kidney Diseases. 2016;67(5):792–810. doi: 10.1053/j.ajkd.2015.07.037. - DOI - PMC - PubMed
    1. Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. Journal of the American Society of Nephrology. 2002;13(9):2384–2398. doi: 10.1097/01.asn.0000028643.17901.42. - DOI - PubMed
    1. Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 2015;88(1):17–27. doi: 10.1038/ki.2015.59. - DOI - PMC - PubMed
    1. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. The New England Journal of Medicine. 2012;367(25):2407–2418. doi: 10.1056/NEJMoa1205511. - DOI - PMC - PubMed

LinkOut - more resources